Clinical Trial Update: Morphine for Treatment of Dyspnea in Patients With COPD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated morphine for treatment of dyspnea in patients with chronic obstructive pulmonary disease. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Morphine (morphine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED